edetic acid has been researched along with mci 9038 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hino, M; Kumura, T; Tatsumi, N; Yamane, T | 1 |
| Chen, W; Cui, M; Jing, R; Wang, H; Xu, L | 1 |
1 review(s) available for edetic acid and mci 9038
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for edetic acid and mci 9038
| Article | Year |
|---|---|
Argatroban as an anticoagulant for both hematologic and chemical tests.
Topics: Anticoagulants; Arginine; Blood Cell Count; Chelating Agents; Chemistry, Clinical; Edetic Acid; Female; Hematology; Humans; Leukocyte Count; Male; Pipecolic Acids; Reproducibility of Results; Sulfonamides | 2000 |
Evaluation of Argatroban as a Potential Anticoagulant for Clinical Laboratory Analysis: Precision, Stability and Interference Study.
Topics: Adult; Anticoagulants; Arginine; Edetic Acid; Erythrocyte Indices; Female; Humans; Male; Pipecolic Acids; Sulfonamides | 2016 |